(Q71043285)
Statements
Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease (English)
Zoldan J
Friedberg G
scientific article published on 01 January 1996